Evidence map›Paper›PMID 25431489›Full record

ArticleScience (New York, N.Y.)2015

Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity.

Timothy J Nice, Megan T Baldridge, Broc T McCune, Jason M Norman, Helen M Lazear, Maxim Artyomov, Michael S Diamond, Herbert W Virgin

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 243 papers.

0numbers the graph read from it
0cells of the map it votes in
243citing papers in PubMed
19.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

243 citing papers in PubMed, 347 citations in OpenAlex.

  1. Early Treatment with Pegylated Interferon Lambda for Covid-19.The New England journal of medicine · 2023
    Trial
  2. Trial
  3. Article
  4. Plscr1 inhibits murine norovirus entry.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Microbiota-dependent IFN-L controls uterine and placental immunity.bioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Interferon-Based Therapeutics in Cancer Therapy: Past, Present, and Future.International journal of molecular sciences · 2025
    Review
  16. Article
  17. Chronic persistent Norovirus in the immune-compromised host.Current opinion in infectious diseases · 2025
    Review
  18. Mechanisms of Differential Signal Transduction by IFNLR1 Variants.bioRxiv : the preprint server for biology · 2025
    Article
  19. Review
  20. Review

183 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Timothy J NiceDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Megan T BaldridgeDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Broc T McCuneDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Jason M NormanDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Helen M LazearDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.
Maxim ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Michael S DiamondDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA. Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Herbert W VirginDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. virgin@wustl.edu.
Washington University in St. Louis · US

Funding

Genetic and Pathway Analysis CoreU19AI109725 · NIAID · WASHINGTON UNIVERSITY · PI ALLEN, PAUL M · 2014 to 2018
$32.7M
Systems Biology Identifies Restriction Factors for West Nile VirusU19AI106772 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI LIVNY, MIRON · 2013 to 2017
$26.1M
West Nile Virus and host control of innate defensesU19AI083019 · NIAID · UNIVERSITY OF WASHINGTON · PI CLARK, EDWARD A · 2009 to 2018
$22.5M
TRAINING PROGRAM IN IMMUNOLOGY AND IMMUNOGENETICST32AI007163 · NIAID · WASHINGTON UNIVERSITY · PI Kenneth M Murphy, Kodi S Ravichandran · 1985 to 2026
$14.8M
TRAINING IN THE IMMUNOBIOLOGY AND MOLECULAR CELL BIOLOGY OF CANCERT32CA009547 · NCI · WASHINGTON UNIVERSITY · PI ROBERT DAVID SCHREIBER · 1986 to 2026
$12.1M
SUSCEPTIBILILTY GENE-VIRUS INTERACTIONS IN INFLAMMATORY BOWEL DISEASER01AI084887 · NIAID · WASHINGTON UNIVERSITY · PI STAPPENBECK, THADDEUS S, VIRGIN, HERBERT W · 2010 to 2014
$1.9M
DEFINING THE IN VIVO ROLE OF DAP1 IN AUTOPHAGY AND COLITISF31CA177194 · NCI · WASHINGTON UNIVERSITY · PI MCCUNE, BROC TAYLOR · 2013 to 2015
$87k
NCI NIH HHS 5T32CA009547NCI NIH HHS F31 CA177194NCI NIH HHS F31CA177194-01NCI NIH HHS T32 CA009547NIAID NIH HHS 5T32AI007163NIAID NIH HHS R01 AI084887NIAID NIH HHS T32 AI007163NIAID NIH HHS U19 AI083019NIAID NIH HHS U19 AI106772NIAID NIH HHS U19 AI109725PHS HHS 5T32A100716334
6 · The paper itself

Abstract

Norovirus gastroenteritis is a major public health burden worldwide. Although fecal shedding is important for transmission of enteric viruses, little is known about the immune factors that restrict persistent enteric infection. We report here that although the cytokines interferon-α (IFN-α) and IFN-β prevented the systemic spread of murine norovirus (MNoV), only IFN-λ controlled persistent enteric infection. Infection-dependent induction of IFN-λ was governed by the MNoV capsid protein and correlated with diminished enteric persistence. Treatment of established infection with IFN-λ cured mice in a manner requiring nonhematopoietic cell expression of the IFN-λ receptor, Ifnlr1, and independent of adaptive immunity. These results suggest the therapeutic potential of IFN-λ for curing virus infections in the gastrointestinal tract.

Indexed as

Adaptive ImmunityAnimalsCaliciviridae InfectionsCapsid ProteinsCells, CulturedCytokinesFecesGastroenteritisImmunity, InnateInterferon-alphaInterferon-betaInterferon LambdaInterleukinsMiceMice, Inbred C57BLNorovirusCapsid ProteinsCytokinesInterferon-alphaInterferon-betaInterferon Lambdainterferon-lambda protein, mouseInterleukins

Identifiers

PMID25431489
PMCPMC4398891
OpenAlexW2077656241

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.